P 400 Atavaquone, a new approach of ocular toxoplasmose treatment  by Hettesheimer, H. & Völker, M.
P 397 P399 
HIGH LRVR1.S OF NEUHON SPECIPIC ENOLASE IN 
SUBRETINAL FLUID DURING RETINAL DETACHMENT 
AOUIDIDI S.‘, COQUEREL A.? and BRASSEUR G’ 
k%ewice d’ophtalmologie, 2Labomtoire de radio-analym, Hopital Charles 
Nicolle, Rouen, France. 
Eurppse : To evaluate the presence of Neuron Specific Enolase (NSE) in 
subretinal fluid (SRF? as a uotential marker for retinal damaee and to 
correlate these b&Vets ‘tith r&al detachment (RD) pzmmwem kS.E is a 
reliablemarkerofneuronallysisintbecerebro-~fluidinbraindamage. 
Levels of NSE in the aqueous humour are also elevated in retiwblastoma 
NSEhaskdetectedinalllayenofnmmal humanretinaexcepth4uller 
cells and retinal pigment epithelimn. 
Methods : SRF and blood samples were collected during RD before 
cryc4hempy (CT) in 3 cases (Group l), a&r CT in 18 cases (Group 2). 
be&Fmzd after CT in 2 cases (Croup 3). NSE was measured with a 
mtoassay (sensitivity In&l). We had no &zence values for 
subretinat fluid Normal range is c 15ng/ml. in aqueous humor (collected in 
10patientspriortocatamctsmgery). 
~:MeanlevelsofNSEinSRFingroup2(1264f881n%ml)- 
significantly higher (p< 0.01) than those in group 1 (157 f 114 n&l). A 
lOfddin-wasnotioed~~intheSRFofbothpetientsofgroup 
3. No conelation could be found between tbe levels of NSE and the 
duration of RD, it’s size, the presence of Pa visual recovery, visual field 
testing or .$e age of the pa!knt, with a 6 months follow up. 
L&&w!u : Elevatimt of NSE levels prim to crycUterapy suggest a 
modemte retinal lysis secondary to RD. Much higher levels of NSE found 
at?erCTintheSRFofthesepaUah suggestanimpcrtantr&aldamage 
relatedwiththisCT.NSEevaluationcouldbeusefultocom~retinal 
damage induced by diode laser therapy versus CT. 
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TITLE: EXPERIMENTAL RETINAL TOXICITY OF 
INTRAVITREAL INJECTION OF LIPOSOME ENCAPBULATED 
S-FLUOROURIDINE 
AUTHORS : Cane-Parra J’, Ruiz-Lapuente C', 
Martinez-Palmer A', Castilla M'. Cerda-Nicol&s M*. 
Diaz M*. 
l.- IMIM, Barcelona. 
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PURPOEE . TO evaluate retinal toxicity of 
-real injection of liposome encapsulated 
5-fluorouridine- (L5-FUR) in-rabbits unbergoing 
experimental PVR.mTHODS A PVR was induced in 9 
pigmented rabbits by criotherapy and gas 
COmpreSSiOn of the vitreous (C3F8). Six eyes were 
injected with 0.1 ml of liposomes containing 5- 
FUR ( lmslml) and 3 control eves were iniected 
with empty liposomes. Eyes ~a-6 enucleated-at 24 
h, 14 days or 28 days for light and electron 
microscopy studies. RESULTS. 
Light and electron microscopic studies showed 
slight vacuolization of outer photorreceptor 
segment in all cases. Nevertheless, effect was 
minimal at 24 h, maximal at 14 days, and slopping 
thereafter until 28 days. 
CONCLUSIONS. Intravitreal injection of liposome 
encapsulated 5-fluorouridine (L5-FUR) in rabbits 
with experimental PVR induced mild toxicity in 
outer photorreceptor layer. 
TITLE: EXPERIMENTAL RETINAL TOXICITY OF 
INTRAVITREAL INJECTION OF MITOMYCIN C 
AUTHORS: Cane-Parra J’, Ruiz-Lapuente C', 
Martinez-Palmer A', Castilla M', Cerdb-Nicolas M', 
Diaz M2. 
l.- IMIM, Barcelona. 
2.- La Fe Hospital, Valencia. 
PVRPOEE . To evaluate retinal toxicity of 
-real injection of mitomycin C in rabbits 
undergoing experimental PVR.NETHODS. PVR was 
induced in 9 pigmented rabbitsbyherapy and 
gas COmprsSSion of the vitreous (C3F8). Six eyes 
were injected with 0.1 ml of mitomycin C ( 0.02 
mg/ml) and 3 control eyes were injected. with 
empty liposomes. Eyes were enucleated at 24 h, 
14 days or 28 da& for light and electron 
microscopy studies. RESULTS Light and electron 
microscopic studies showedlight vacuolization 
of outer photorreceptor segment in all cases. 
Nevertheless, effect was maximal at 24 h, and 
sloppinq thereafter until 28 davs. 
CON&ISiONS. Intravitreal injection of mitomycin 
C in rabbits with exoerimental PVR induced mild 
acute toxicity in ou&r photorreceptor layer. 
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ATAVAQUONE, A NEW APPROACH OF OCULAR TOXOPLASMOSE 
TREATMENT 
HElTESHEIMERH.andVCjLKERM 
University Eye "ink Tihingen, Gemany 
Eurppse: Cerebral toxoplasmosis is the nwst common opportunistic mfection of 
the central nervous system in AIDS-patients. The treatment of ocular 
toxoplasmosis with c&entional drug r$mes sulphadiacin’or clindamycin 
plus pyrimethamine can occasionally produce swerc side effects and 
adverse reactions. But maintenance therapy must be continued for life time 
because of the high recurrence rates. Atavaquone is a new hydroxy- 
naphthoquione which is tolerated excellently by the pattients The drug is 
very effective against tachycoits of toxoplasma gcmdii and its cysts as well. 
-A 29-yeardld female with HIV-infection developed an allergic 
rash after being treated with a course of pyrimethamine and clindamycin 
(Sobellin) for unilateral, unifocal ocular toxoplasmosis for 14 days. Therapy 
with atovaquone (4 x 750 mg/dl was administered. Within I4 days the 
infiltrate disappeared resulting a chorioretinal scar. 
j3smk The oral treatment with atovaquone (4 x 750 mg/d) was not 
accompanied with allergic complications. During maintenance therapy with 
atovaquone (3 x 7% mg/dl no rearrency occurred during a period of 9 month. 
The vitreous haze stadily decreased and the chorioretinal scar was 
pigmented. 
Conclusion: In this patient atovaquone proved to be an effective and well 
tolerated drug for the treatment of ocular toxoplasmosis. It might believe 
that atcwaquone is a valid alternate to standard drugs such as renmws with 
pyrimethakine, clindamycin or sulfonamides wh;h otherwisp are often 
complicated by toxic side effects and allergic reactions. Future clinical 
investigations will have to evaluate whether atovaquone will be a real 
alternate in longterm treatment of ocular toxoplasmosis. 
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